Lyndra Therapeutics Announces Adam Sayer Appointed President and CEO

Lyndra Therapeutics, a clinical-stage biopharmaceutical company pioneering long-acting oral therapies, announced the Board of Directors has appointed Adam Sayer as President and Chief Executive Officer effective immediately. He will also serve on the company’s Board of Directors. Sayer was most recently Chief Transfo…